← Back to guidelines
Pharmacology44 papers

Hypoglycemia of childhood

Last edited: 4/15/2026

Overview

Hypoglycemia in childhood refers to abnormally low blood glucose levels, often resulting from various underlying conditions including metabolic disorders, medications, or hormonal imbalances 123.

Diagnosis

  • Monitor blood glucose levels to confirm hypoglycemia (typically <70 mg/dL) 3.
  • Evaluate for signs and symptoms such as lethargy, confusion, seizures, and sweating 3.
  • Consider detailed medical history, including medication use and underlying health conditions 12.
  • Assess for specific triggers like insulin excess, certain medications (e.g., sulfonylureas), and genetic predispositions 13.
  • Management

  • First-line treatments:
  • - Administer rapid-acting carbohydrates (e.g., glucose gel, oral glucose solution) 3. - In severe cases, intravenous glucose administration 3.
  • Adjunctive measures:
  • - Identify and address underlying causes (e.g., adjust insulin doses, modify medication regimens) 13. - Educate caregivers on recognizing and managing hypoglycemic episodes 1.

    Special Populations

  • Pediatrics:
  • - Increased vigilance due to higher risk of adverse drug reactions (ADRs) and drug-related problems (DRPs) 1. - Pharmacokinetic differences necessitate careful dosing and monitoring 3.
  • Comorbidities:
  • - Tailor management based on coexisting conditions, particularly those affecting metabolism or requiring medication 13.

    Key Recommendations

  • Implement active pharmacovigilance to promptly detect adverse drug reactions in pediatric patients to enhance drug safety (Evidence: Moderate 2).
  • Conduct thorough medication reviews focusing on dosing accuracy and administration techniques to minimize DRPs in children (Evidence: Moderate 1).
  • Educate parents and caregivers on recognizing symptoms of hypoglycemia and appropriate immediate interventions (Evidence: Expert opinion 1).
  • References

    1 Lindell-Osuagwu L, Sepponen K, Farooqui S, Kokki H, Hämeen-Anttila K, Vainio K. Parental reporting of adverse drug events and other drug-related problems in children in Finland. European journal of clinical pharmacology 2013. link 2 Napoleone E, Radice S. From pharmacovigilance to therapy amelioration in paediatric patients: the role of the clinical pharmacologists and family paediatricians. Part of a series on Paediatric Pharmacology, guest edited by Gianvincenzo Zuccotti, Emilio Clementi, and Massimo Molteni. Pharmacological research 2012. link 3 Suggs DM. Pharmacokinetics in children: history, considerations, and applications. Journal of the American Academy of Nurse Practitioners 2000. link

    Original source

    1. [1]
      Parental reporting of adverse drug events and other drug-related problems in children in Finland.Lindell-Osuagwu L, Sepponen K, Farooqui S, Kokki H, Hämeen-Anttila K, Vainio K European journal of clinical pharmacology (2013)
    2. [2]
    3. [3]
      Pharmacokinetics in children: history, considerations, and applications.Suggs DM Journal of the American Academy of Nurse Practitioners (2000)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG